ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
CVR number: 32323502
Tuborg Boulevard 12, 2900 Hellerup
Income statement (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Costs of manufacturing | -30.40 | ||||
| Gross profit | -1.85 | -30.40 | -6.05 | -8 328.99 | -44 610.52 |
| Costs of management | - 118.78 | -95.31 | -88.04 | -89.54 | -8.75 |
| EBIT | - 120.63 | - 125.71 | -94.08 | -8 418.53 | -44 619.27 |
| Other financial income | 351.28 | 358.57 | 365.05 | 320.75 | 202.42 |
| Other financial expenses | -0.28 | -0.37 | -0.08 | -0.35 | - 135.80 |
| Pre-tax profit | 230.37 | 232.49 | 270.89 | -8 098.13 | -44 552.65 |
| Income taxes | -19.95 | -35.52 | -57.87 | 8.41 | 61.55 |
| Net earnings | 210.42 | 196.96 | 213.02 | -8 089.72 | -44 491.10 |
Assets (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 14 400.28 | 14 583.44 | 14 798.86 | ||
| Prepayments and accrued income | 1 059.76 | ||||
| Current other receivables | 6.04 | 6.59 | 5.66 | 5 661.99 | |
| Short term receivables total | 14 406.32 | 14 590.04 | 14 804.52 | 6 721.75 | |
| Cash and bank deposits | 5.62 | 21.65 | 17.06 | 11.63 | 7.64 |
| Cash and cash equivalents | 5.62 | 21.65 | 17.06 | 11.63 | 7.64 |
| Balance sheet total (assets) | 14 411.94 | 14 611.69 | 14 821.58 | 6 733.38 | 7.64 |
Equity and liabilities (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 134.04 | 134.04 | 134.04 | 134.04 | 134.04 |
| Shares repurchased | -8 089.72 | -44 491.10 | |||
| Other reserves | 8 089.72 | 44 491.10 | |||
| Retained earnings | 14 059.78 | 14 270.20 | 14 467.17 | 14 680.18 | 6 590.46 |
| Profit of the financial year | 210.42 | 196.96 | 213.02 | -8 089.72 | -44 491.10 |
| Shareholders equity total | 14 404.25 | 14 601.21 | 14 814.23 | 6 724.51 | -37 766.60 |
| Non-current owed to group member | 37 763.82 | ||||
| Non-current liabilities total | 37 763.82 | ||||
| Short-term deferred tax liabilities | 8.88 | 10.41 | |||
| Other non-interest bearing current liabilities | 7.70 | 10.48 | 7.36 | ||
| Current liabilities total | 7.70 | 10.48 | 7.36 | 8.88 | 10.41 |
| Balance sheet total (liabilities) | 14 411.94 | 14 611.69 | 14 821.58 | 6 733.38 | 7.64 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.